251 related articles for article (PubMed ID: 31586799)
1. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
[TBL] [Abstract][Full Text] [Related]
2. Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.
Sanaie S; Koohi N; Mosaddeghi-Heris R; Rezai S; Movagharnia E; Karimi H; Moghaddamziabari S; Hamzehzadeh S; Gholipour-Khalili E; Talebi M; Naseri A
Mult Scler Relat Disord; 2024 May; 85():105530. PubMed ID: 38522226
[TBL] [Abstract][Full Text] [Related]
3. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
[TBL] [Abstract][Full Text] [Related]
4. The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder.
Rezaeimanesh N; Saeedi R; Sahraian MA; Razeghi Jahromi S; Naser Moghadasi A
Mult Scler Relat Disord; 2020 Jul; 42():102132. PubMed ID: 32387974
[TBL] [Abstract][Full Text] [Related]
5. The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder.
Rezaeimanesh N; Saeedi R; Sahraian MA; Ghadiri F; Naser Moghadasi A
Curr J Neurol; 2022 Apr; 21(2):74-82. PubMed ID: 38011484
[No Abstract] [Full Text] [Related]
6. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
[TBL] [Abstract][Full Text] [Related]
7. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
[TBL] [Abstract][Full Text] [Related]
8. The relationship between cognitive function and body mass index in multiple sclerosis patients.
Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
[TBL] [Abstract][Full Text] [Related]
9. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
[TBL] [Abstract][Full Text] [Related]
10. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcome measurements in a selective cohort of relapsing-remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics.
London F; El Sankari S; De Haan A; Benyahia Z; Landenne G; Duprez T; van Pesch V
Acta Neurol Belg; 2023 Jun; 123(3):1049-1059. PubMed ID: 36877357
[TBL] [Abstract][Full Text] [Related]
12. Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
Vázquez-Marrufo M; Galvao-Carmona A; Caballero-Díaz R; Borges M; Paramo MD; Benítez-Lugo ML; Ruiz-Peña JL; Izquierdo G
PLoS One; 2019; 14(7):e0219594. PubMed ID: 31306457
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
14. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
15. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
Nelson F; Akhtar MA; Zúñiga E; Perez CA; Hasan KM; Wilken J; Wolinsky JS; Narayana PA; Steinberg JL
Mult Scler; 2017 May; 23(6):836-847. PubMed ID: 27613119
[TBL] [Abstract][Full Text] [Related]
16. The Bayesian risk estimate at onset (BREMSO) correlates with cognitive and physical disability in patients with early multiple sclerosis.
Said M; El Ayoubi NK; Hannoun S; Haddad R; Saba L; Jalkh Y; Yamout BI; Khoury SJ
Mult Scler Relat Disord; 2018 Nov; 26():96-102. PubMed ID: 30243236
[TBL] [Abstract][Full Text] [Related]
17. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
Okada K; Kakeda S; Tahara M
Mult Scler Relat Disord; 2020 Feb; 38():101507. PubMed ID: 31766000
[TBL] [Abstract][Full Text] [Related]
18. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
[TBL] [Abstract][Full Text] [Related]
19. Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.
Hawkins R; Shatil AS; Lee L; Sengupta A; Zhang L; Morrow S; Aviv RI
AJNR Am J Neuroradiol; 2020 Mar; 41(3):449-455. PubMed ID: 32079601
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.
Ozakbas S; Turkoglu R; Tamam Y; Terzi M; Taskapilioglu O; Yucesan C; Baser HL; Gencer M; Akil E; Sen S; Turan OF; Sorgun MH; Yigit P; Turkes N
Mult Scler Relat Disord; 2018 May; 22():70-76. PubMed ID: 29605801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
